Literature DB >> 20960565

Association between expression of embryonic lethal abnormal vision-like protein HuR and cyclooxygenase-2 in oral squamous cell carcinoma.

Jeong-Dan Cha1, ShengJin Li, In-Ho Cha.   

Abstract

BACKGROUND: Increased cytoplasmic HuR expression has been noted in several cancer types, where it may contribute to the increased cyclooxygenase-2 (COX-2) expression observed during tumorigenesis and metastasis.
METHODS: To assess the correlation between COX-2 and HuR in oral squamous cell carcinoma (OSCC), the expression patterns of HuR and COX-2 were assessed via immunohistochemistry analyses of 103 OSCC samples.
RESULTS: Cytoplasmic HuR expression was significantly associated with COX-2 expression (p < .025) and lymph node metastasis (p < .050) and distant metastasis (p < .025). In multivariate analysis, cytoplasmic HuR expression was identified as an independent prognostic parameter for reduced overall survival. The inhibition of HuR expression by siRNA or leptomycin B (LMB) caused a reduction in the inducibility of COX-2 in oral cancer cells.
CONCLUSION: Our results indicate that the cytoplasmic expression of HuR is associated with COX-2 expression in OSCCs and HuR can regulate COX-2 expression in oral cancer cell lines.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960565     DOI: 10.1002/hed.21507

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  18 in total

Review 1.  Control of cytokine mRNA expression by RNA-binding proteins and microRNAs.

Authors:  V Palanisamy; A Jakymiw; E A Van Tubergen; N J D'Silva; K L Kirkwood
Journal:  J Dent Res       Date:  2012-02-01       Impact factor: 6.116

Review 2.  Clinical significance of HuR expression in human malignancy.

Authors:  Ioly Kotta-Loizou; Constantinos Giaginis; Stamatios Theocharis
Journal:  Med Oncol       Date:  2014-08-13       Impact factor: 3.064

Review 3.  Human antigen R and drug resistance in tumors.

Authors:  Fenghai Zhou; Fa Zhang; Chuan Zhou; Mengtian Liang; Zhonglin Cai; Haidi Lv; Wenjuan Li; Xupan Wei
Journal:  Invest New Drugs       Date:  2019-01-05       Impact factor: 3.850

4.  Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma.

Authors:  Cong Zhang; Guoliang Xue; Jingwang Bi; Ming Geng; Huili Chu; Yaping Guan; Jun Wang; Baocheng Wang
Journal:  Tumour Biol       Date:  2013-07-20

5.  Diclofenac sodium gel therapy as an alternative to actinic cheilitis.

Authors:  Amanda Katarinny Goes Gonzaga; Patrícia Teixeira de Oliveira; Éricka Janine Dantas da Silveira; Lélia Maria Guedes Queiroz; Ana Miryam Costa de Medeiros
Journal:  Clin Oral Investig       Date:  2017-10-06       Impact factor: 3.573

Review 6.  Multiple functions of HuR in urinary tumors.

Authors:  Fa Zhang; Zhonglin Cai; Haidi Lv; Wenjuan Li; Mengtian Liang; Xupan Wei; Fenghai Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-28       Impact factor: 4.553

7.  Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions.

Authors:  Constantinos Giaginis; Paraskevi Alexandrou; Ioanna Delladetsima; Ioannis Karavokyros; Eugene Danas; Athina Giagini; Efstratios Patsouris; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2016-01       Impact factor: 3.201

8.  Revisiting the association between candidal infection and carcinoma, particularly oral squamous cell carcinoma.

Authors:  Marina Mohd Bakri; Haizal Mohd Hussaini; Ann Rachel Holmes; Richard David Cannon; Alison Mary Rich
Journal:  J Oral Microbiol       Date:  2010-12-21       Impact factor: 5.474

Review 9.  Abnormal COX2 protein expression may be correlated with poor prognosis in oral cancer: a meta-analysis.

Authors:  Zhi-Ming Wang; Jie Liu; Hong-Bo Liu; Ming Ye; Yu-Fei Zhang; Dong-Sheng Yang
Journal:  Biomed Res Int       Date:  2014-06-16       Impact factor: 3.411

Review 10.  Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis.

Authors:  Jun Wang; Yan Guo; Huili Chu; Yaping Guan; Jingwang Bi; Baocheng Wang
Journal:  Int J Mol Sci       Date:  2013-05-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.